Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features

OBJECTIVE To investigate immunohistochemical markers of angiogenesis and their association with pathological prognostic features in hepatocellular carcinoma and cirrhotic liver. METHODS Vascular endothelial growth factor, CD105, and cyclooxygenase-2 were immunohistochemically detected in 52 hepatoc...

Full description

Bibliographic Details
Main Authors:	Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain
Format:	Article
Language:	English
Published:	Elsevier España
Series:	Clinics
Subjects:	vegf cd105 cox-2 hepatocellular carcinoma cirrhosis pathology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322016001100639&lng=en&tlng=en

Similar Items

Relevance of morphological features for hepatocellular adenoma classification in pathology practice
by: Carla Henriques Agostini, et al.
Published: (2020-03-01)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
by: Krizia Pocino, et al.
Published: (2021-12-01)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
by: Dong W, et al.
Published: (2020-07-01)

Immunohistochemical characteristics of the angiogenesis processes in brain tissue in diabetes mellitus type 2
by: Avramenko Yu. M.
Published: (2020-06-01)

Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008-07-01)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
by: Ana Nogués, et al.
Published: (2020-05-01)

Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy
by: Rahmawati Minhajat, et al.
Published: (2021-05-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers
by: Michelle Etienne Baptistella Florence, et al.
Published: (2011-01-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
by: Ji Hyun Kim, et al.
Published: (2020-11-01)

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review
by: Altshuler E, et al.
Published: (2022-12-01)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
by: Yi-Te Lee, et al.
Published: (2023-04-01)

Angiogenic squamous dysplasia-like phenomenon in oral epithelial precursor lesions
by: Siar CH, et al.
Published: (2009-07-01)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
by: Virginia Di Paolo, et al.
Published: (2018-01-01)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
by: Ruipeng Zheng, et al.
Published: (2020-06-01)

Immunohistochemical Markers of Local Tissue Response to the Implantation of Products Made from PHA
by: Yuri S. Vinnik, et al.
Published: (2016-03-01)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
by: Alberto Zanetto, et al.
Published: (2021-03-01)

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
by: Huarong Zhang, et al.
Published: (2023-03-01)

Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis
by: Ivan Chebib, et al.
Published: (2007-01-01)

Liver Cirrhosis and Hepatocellular Carcinoma Diagnosed from Chylothorax: A Case Report
by: Kenta Ito, et al.
Published: (2021-09-01)

Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
by: Iuliana Nenu, et al.
Published: (2022-02-01)

Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
by: Hiroya Iida, et al.
Published: (2020-03-01)

Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development
by: Shan Shan, et al.
Published: (2019-04-01)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
by: Zhaobin He, et al.
Published: (2022-03-01)

OVEREXPRESSION OF VEGF AND VEGFR2 IN CHRONIC HEPATITIS AND LIVER CIRRHOSIS
by: Raluca Amalia Ceauşu, et al.
Published: (2016-12-01)

Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019-01-01)

The Predictive Value of ALBI and P-ALBI Scores in The Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis
by: Tolga ŞAHİN, et al.
Published: (2019-12-01)

Evaluation the Expression of Endoglin (CD105) & IL-3 Level of Pregnancy Women with Antiphospholipid Syndrome
by: Manal Salih
Published: (2019-05-01)

Evaluation the Expression of Endoglin (CD105) & IL-3 Level of Pregnancy Women with Antiphospholipid Syndrome
by: Manal Salih
Published: (2019-05-01)

Evaluation the Expression of Endoglin (CD105) & IL-3 Level of Pregnancy Women with Antiphospholipid Syndrome
by: Manal Salih
Published: (2019-05-01)

A Novel CD105 Determination System Based on an Ultrasensitive Bioelectrochemical Strategy with Pt Nanoparticles
by: Zhiqing Liang, et al.
Published: (2012-10-01)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
by: António G. P. Bastos, et al.
Published: (2022-09-01)

Fas/FasL polymorphisms are associated with hepatitis C related cirrhosis and serum Alpha-Fetoprotein with hepatocellular carcinoma patients
by: Guo-Shiou Liao, et al.
Published: (2016-03-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
by: Hao-dan Mao, et al.
Published: (2023-03-01)

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
by: Yang SH, et al.
Published: (2024-04-01)

Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
by: Silvia Ferri, et al.
Published: (2022-06-01)